Award details

Unlocking the complement-suppressing potential of factor H with a bacterial polypeptide

ReferenceBB/L024403/1
Principal Investigator / Supervisor Professor Paul Barlow
Co-Investigators /
Co-Supervisors
Institution University of Edinburgh
DepartmentSch of Chemistry
Funding typeResearch
Value (£) 172,807
StatusCompleted
TypeResearch Grant
Start date 01/04/2014
End date 31/03/2015
Duration12 months

Abstract

unavailable

Summary

A challenge in medicine is that contact between blood and manmade devices (such as intra-vascular stents used in cardiac surgery or dialysis equipment for kidney-failure patients) can trigger part of the human immune system called the complement cascade, with dire clinical consequences. We discovered that PspCN, a polypeptide of microbial origin, "turbocharges" a human protein (CFH) that inhibits the complement cascade. Guided by the results of a market assessment, we now propose to design, manufacture and test PspCN-decorated surface coatings for medical implants. We aim to demonstrate that the PspCN displayed on these potentially protective coatings will grab hold of CFH, which is abundant in blood, and induce the captured CFH to switch from a latent to an activated form. Thus, in an improvement on the efforts of competitors to utilize CFH in its latent form, our approach will afford coated surfaces that are protected from the complement cascade by the patient's own, activated, CFH.
Committee Not funded via Committee
Research TopicsMicrobiology, Pharmaceuticals
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund (FOF) [2004-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file